>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

Application for Distribution License for CROSSWALK®, Reverse CROSSWALK® or Relative Value Guide®

ASA is the sole owner of copyright rights in CROSSWALK®, Reverse CROSSWALK® and Relative Value Guide®. A license is required to use or reprint content from these publications to create any product or publication intended for sale or distribution in the U.S. or abroad.

Each license will grant a non-exclusive right to use content from the current editions of CROSSWALK®, Reverse CROSSWALK® and/or Relative Value Guide®. Use of content from past editions may also be permitted as deemed appropriate. Distribution may be in print, electronic media, or over the Internet. Reasonable royalties to ASA may be required with reports to be submitted quarterly.

Please note that using or reprinting content from these publications requires use of the nomenclature developed and copyrighted by the American Medical Association in its Current Procedural Terminology, 4th Edition (CPT-4) publication. A separate license with the AMA for use of the CPT® codes contained within the ASA publications is required.

For further information please contact ASA Associate General Counsel, at m.kuffner@asawash.org.

Click here to obtain an application for a distribution license (PDF) or distribution license (Word) or a royalty report (PDF) or royalty report (Word).